GLP-1 (Glucagon-Like Peptide-1) receptor agonistslike semaglutide or tirzepatideare injectable medications that assist in weight loss by regulating appetite, improving insulin sensitivity, and slowing gastric emptying
Your first month is spent on the lowest 1.5 mg dose, which is there to help your body adjust to the medication rather than to produce the greatest weight loss
Dose escalation may be appropriate for some uses starting with lower doses (0.1mL) and gradually increasing to higher doses (0.3mL) based on tolerance and response
Monitoring Progress and Optimizing Results Monitoring your progress and optimizing the outcomes of your treatment, including the use of semaglutide, is critical for effectively managing type 2 diabetes
Leptin activates neurons in ventrobasal hypothalamus and brainstem
[DOI] [PMC free article] [PubMed] [Google Scholar] 65.Liu C, Fu H, Li J, Yang W, Cheng L, Liu T